Skip to content

Clinical trials

Cerebrovascular Disorders trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cerebrovascular Disorders Country / region: Russia Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20141
20151
20181
20191
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated4
Completed2
Active, not recruiting1
Enrolling by invitation1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer1
Central Clinical Hospital of the Russian Academy of Sciences1
Litvina Lyubov Dmitrievna1
National Heart, Lung, and Blood Institute (NHLBI)1
National Medical Research Center for Therapy and Preventive Medicine1
Pharmasoft1
Remedy Pharmaceuticals, Inc.1
Tatchempharmpreparaty, JSC1
Ural State Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cerebrovascular Disorders9
Stroke4
Central Nervous System Diseases2
Coronary Artery Disease2
Ischemic Stroke2
Alzheimer Disease1
Anemia, Sickle Cell1
Angina, Stable1
Asthma1
Brain Diseases1

Trials

Showing 76 to 9 of 9. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.